More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$103817101
EPS
-0.18
P/E ratio
--
Price to sales
0.77
Dividend yield
--
Beta
2.301982
Previous close
$1.27
Today's open
$1.28
Day's range
$1.26 - $1.47
52 week range
$1.15 - $11.93
show more
CEO
Yogesh Jashnani
Employees
422
Headquarters
Miami Beach, FL
Exchange
NASDAQ Global Market
Shares outstanding
72095209
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AirSculpt Technologies, Inc. - AIRS
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
GlobeNewsWire • Oct 6, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS
NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AirSculpt Technologies, Inc. ("AirSculpt" or the "Company") (NASDAQ: AIRS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
PRNewsWire • Oct 1, 2026

AIRS Investors Have Opportunity to Join AirSculpt Technologies, Inc. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $AIRS--AIRS Investors Have Opportunity to Join AirSculpt Technologies, Inc. Fraud Investigation with SBS Law.
Business Wire • Sep 19, 2026

Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze.
Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgery.
Market Watch • Sep 5, 2026

AirSculpt Sees Core Stabilization, Targets $100M-Plus GLP-1 Opportunity
AirSculpt Technologies NASDAQ: AIRS is seeing stabilization in its core body-contouring business after several quarters of declines, while expanding services aimed at patients using GLP-1 weight-loss drugs, Chief Executive Officer Yogi Jashnani said at a Canaccord consumer conference.
MarketBeat • Aug 11, 2026

AirSculpt Technologies Q2 Earnings Call Highlights
AirSculpt Technologies NASDAQ: AIRS reported second-quarter revenue of $42.9 million, down 2.5% from the prior-year period, as the company cited stable revenue trends, positive same-center case growth and continued investment in marketing and expanded procedure offerings.
MarketBeat • Aug 10, 2026

AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call Transcript
AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call Transcript
Seeking Alpha • Aug 10, 2026

AirSculpt Technologies Reports Second Quarter Fiscal 2026 Results
MIAMI BEACH, Fla., Aug. 10, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the second quarter ended June 30, 2026.
GlobeNewsWire • Aug 10, 2026

Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday.
Benzinga • Aug 10, 2026

AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Second Quarter Fiscal 2026 Results
Company to Participate in Canaccord Genuity's 46th Annual Growth Conference Company to Participate in Canaccord Genuity's 46th Annual Growth Conference
GlobeNewsWire • Aug 3, 2026

¹ Disclosures

Open an M1 investment account to buy and sell AirSculpt Technologies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.